Gthread Digests

Colon Cancer Digest


Long-Term Survival Benefits in Colon Cancer With Oxaliplatin

Oxaliplatin "should now be considered standard treatment for stage III colon cancer," said presenting author Hans-Joachim Schmoll, MD, from the University Clinic Halle (Saale) in Germany. In this phase 3 randomized trial, 1806 patients with stage III

Long-Term Survival Benefits in Colon Cancer With Oxaliplatin

Posted in Digest | Leave a comment

 

Comments are closed.

Copyright 2010. Keith P. Graham

 

Based on the 5 minute Roll Your Own Theme